Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Americann Inc. (OTC: ACAN).

Full DD Report for ACAN

You must become a subscriber to view this report.


Recent News from (OTC: ACAN)

AmeriCann Engages Award Winning Public Relations Firm
Publicly Traded Cannabis Company Announces Launch of Public Relations Campaign with Teak Media + Communication DENVER, CO / ACCESSWIRE / August 23, 2018 / AmeriCann, Inc. (OTCQB: ACAN ), an agricultural-technology company that is developing the next generation of eco-friendly state-of-...
Source: ACCESSWIRE
Date: August, 23 2018 08:30
5 of Today's Biggest Marijuana Stock Losers - Wednesday, July 25th
Out of over 200+ marijuana stocks, here are just 5 of the biggest marijuana stock losers in trading on Wednesday, July 25th including AXIM Biotechnologies, Inc. (OTC:AXIM) and more... Affinor Growers Inc. (CSE:AFI) (OTC:RSSFF) Shares of Affinor Growers Inc. dropped 25.00% today on highe...
Source: Daily Marijuana Observer
Date: July, 25 2018 16:41
Americann Completes $3,800,000 Equity Financing
Proceeds to Be Used for Construction of Massachusetts Cannabis Center DENVER, CO / ACCESSWIRE / July 18, 2018 / AmeriCann, Inc. (OTCQB: ACAN ), an agricultural-technology company that is developing the next generation state-of-the-art greenhouse cannabis cultivation and processing prop...
Source: ACCESSWIRE
Date: July, 18 2018 08:30
Americann Partnership with C3RN Commences Cannabis Research In Massachusetts
- First of its Kind study in Massachusetts Designed to Research Cannabis in Legal Markets - Compliments an Ongoing National C3RN Survey with University of Massachusetts Dartmouth DENVER, CO / ACCESSWIRE / July 9, 2018 / AmeriCann, Inc. (OTCQB: ACAN ), an agricultural-technology co...
Source: ACCESSWIRE
Date: July, 09 2018 08:30
Americann CEO to Present at Science and Education Conference in Massachusetts
Event Focuses on Cannabis Cultivation and Extraction Best Practices and Standards DENVER, CO / ACCESSWIRE / June 28, 2018 / AmeriCann, Inc. (OTCQB: ACAN ), an Agricultural-Technology company that is developing the next generation of eco-friendly state-of-the-art greenhouse cannabis cul...
Source: ACCESSWIRE
Date: June, 28 2018 08:30
AmeriCann Partners with C3RN to Conduct Scientific Cannabis Research in Massachusetts
Research to Commence Immediately with Highly Regarded Team of PhDs, Scientists and Professionals DENVER, CO / ACCESSWIRE / June 20, 2018 / AmeriCann, Inc. (OTCQB: ACAN ), an Agricultural-Technology company that is developing the next generation of eco-friendly state-of-the-art greenho...
Source: ACCESSWIRE
Date: June, 20 2018 08:30
AmeriCann CEO to Present at Massachusetts State House News Forum
DENVER, CO / ACCESSWIRE / June 19, 2018 / AmeriCann, Inc. (OTCQB: ACAN ), an Agricultural-Technology company that is developing the next generation of eco-friendly state-of-the-art greenhouse style cannabis cultivation and processing properties, announced today that CEO Tim Keogh will be sp...
Source: ACCESSWIRE
Date: June, 19 2018 16:00
5 of Today's Biggest Marijuana Stock Losers - Monday, June 18th
Out of over 200+ marijuana stocks, here are just 5 of the biggest marijuana stock losers in trading on Monday, June 18th including InMed Pharmaceuticals, Inc. (TSXV:IN) (OTC:IMLFF) and more... Abattis Bioceuticals Corp. (CSE:ATT) (OTC:ATTBF) Shares of Abattis Bioceuticals Corp. dropped 4...
Source: Daily Marijuana Observer
Date: June, 18 2018 16:43
AmeriCann Honored As Best For Workers, Creating Most Positive Impact For Employees
Award Based on Evaluation by Comprehensive B Impact Assessment DENVER, CO / ACCESSWIRE / June 12, 2018 / AmeriCann, Inc. (OTCQB: ACAN ), Today AmeriCann, an Agricultural-Technology company that is developing the next generation of sustainable, state-of-the-art cannabis cultivation prop...
Source: ACCESSWIRE
Date: June, 12 2018 08:30
5 of Today's Biggest Marijuana Stock Losers - Tuesday, June 5th
Out of over 200+ marijuana stocks, here are just 5 of the biggest marijuana stock losers in trading on Tuesday, June 5th including mCig Inc. (OTC:MCIG) and more... Abattis Bioceuticals Corp. (CSE:ATT) (OTC:ATTBF) Shares of Abattis Bioceuticals Corp. dropped 5.45% today on higher than aver...
Source: Daily Marijuana Observer
Date: June, 05 2018 16:42

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-141.851.891.951.8038,365
2018-12-132.051.902.0651.8270,504
2018-12-122.102.052.102.0396,734
2018-12-112.142.092.142.0752,334
2018-12-102.1852.142.252.0632,704

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-146,75338,36517.6020Cover
2018-12-1310,66870,50415.1311Cover
2018-12-1222,17196,73422.9196Cover
2018-12-1114,48452,33427.6761Cover
2018-12-108,29332,70425.3578Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on ACAN.


About Americann Inc. (OTC: ACAN)

Logo for Americann Inc. (OTC: ACAN)

AmeriCann, Inc. develops, owns and supports advanced medical cannabis cultivation and processing facilities nationwide. The Company has a multi market portfolio of over , , square feet of sustainable cannabis production infrastructure in various stages of development. AmeriCann s team includes experts in traditional horticulture, lean manufacturing, medical research, facility construction, regulatory compliance, security, marijuana cultivation and genetics, extraction processes, and infused product development. To support local businesses that seek to serve cannabis patients in their communities we initiated the AmeriCann Preferred Partner Program. Through this program we provide an essential set of resources including advance cultivation facilities, access to a team of experts and in certain cases, capital for our partner s businesses. In addition, AmeriCann s team has been instrumental in winning cannabis licenses in competitive application processes throughout the country. This support is designed to assist our Preferred Partners in newly regulated markets. AmeriCann leases facilities to our Preferred Partners that are designed with AmeriCann s propriety cultivation and processing system called Cannopy. AmeriCann developed Cannopy with experts from traditional horticulture, lean manufacturing, regulatory compliance and cannabis cultivation. Cannopy includes automation throughout the production life cycle, customized workflow processes, monitoring and controls, and top line security systems. Cannopy empowers Preferred Partners to consistently produce medical marijuana for patients at the lowest cost in the most efficient, compliant manner. We provide initial and on going training, policies, practices and procedures to operate the state of the art facilities. The expanding cannabis industry requires extensive real estate to meet the growing needs of patients. AmeriCann utilizes a proven strategy for identifying, acquiring and developing real estate specifically suited for cannabis operations. AmeriCann assists our Preferred Partners with the identification, design, permitting, acquisition, development and operation of scalable infrastructure to cultivate and to dispense medical marijuana in regulated markets. As an early market participant, the Company plans to leverage its leadership in a formative industry to establish a dominant position as the cannabis industry expands. More information about the Company is available at https://americann.co

 

Contact Information

 

 

Current Management

  • Timothy Keogh / CEO
    • Mr. Keogh offers a unique combination of firsthand experience in the cannabis industry, from licensing to operations in numerous states, and an extensive background in real estate development. He is a director of one of fifteen Provisionally Registered marijuana dispensaries in Massachusetts, a board member of the Cannabis Producers Association of New England, and an active member and invited speaker for the National Cannabis Industry Association. He received a BS in business administration from Mount St. Mary s College.
  • Benjamin J. Barton / CFO
    • Mr. Barton has been the managing director of a Coloradobased venture capital and private equity firm since . He has extensive experience in the public and private capital markets, and has been instrumental in raising of over million in equity and debt financing for emerging companies over the past decade. He earned an MBA in finance from UCLA.
  • Timothy Keogh /
    • Mr. Keogh offers a unique combination of firsthand experience in the cannabis industry, from licensing to operations in numerous states, and an extensive background in real estate development. He is a director of one of fifteen Provisionally Registered marijuana dispensaries in Massachusetts, a board member of the Cannabis Producers Association of New England, and an active member and invited speaker for the National Cannabis Industry Association. He received a BS in business administration from Mount St. Mary s College.

Current Share Structure

  • Market Cap: $47,059,380 - 03/09/2018
  • Authorized: 100,000,000 - 02/08/2018
  • Issue and Outstanding: 19,366,000 - 02/12/2018
  • Float: 7,425,000 - 05/08/2017

 


Recent Filings from (OTC: ACAN)

Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(6) under the Act
Filing Type: DFiling Source: edgar
Filing Date: May, 18 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 15 2018
Notice from the SEC of registration effectiveness
Filing Type: EFFECTFiling Source: edgar
Filing Date: May, 09 2018
Amendment to general form for registration of securities under the Securities Act of 1933
Filing Type: S-1/AFiling Source: edgar
Filing Date: May, 04 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 24 2018
General form for registration of securities under the Securities Act of 1933
Filing Type: S-1Filing Source: edgar
Filing Date: April, 12 2018
Amendment to a previously filed 8-K
Filing Type: 8-K/AFiling Source: edgar
Filing Date: March, 21 2018
OTCQB Certification - OTCQB Certification
Filing Type: OTCQB Certification - OTCQB CertificationFiling Source: OTC Markets
Filing Date: March, 08 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: February, 20 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 20 2018

 

 


Daily Technical Chart for (OTC: ACAN)

Daily Technical Chart for (OTC: ACAN)


Stay tuned for daily updates and more on (OTC: ACAN)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: ACAN)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in ACAN is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of ACAN and does not buy, sell, or trade any shares of ACAN. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/